Title
Author
DOI
Article Type
Special Issue
Volume
Issue
An advanced case of double primary malignancy involving the breasts and uterine cervix: satisfactory response to non-surgical management
1Head of Department of Obstetrics & Gynaecology, Cameroon
2Department of Medical Oncology, Cameroon
3Department of Radiotherapy, General Hospital, Yaounde, Cameroon
*Corresponding Author(s): A. S. DOH E-mail:
Double primary cancers are fairly rare. We report here a case of metachronous lesions; advanced cancer of the breasts and squamous cell carcinoma of the cervix. What is peculiar in this case is the rather unusual positive response to conservative treatment. Despite widespread metastases even to the liver, the patient is well and active more than six years after breast cancer was first diagnosed. Treating such advanced cases may be rewarding at times.
Advanced double primary malignancies; unusual response to conservative management
A. S. DOH ,P. Ndom,J. Yomi. An advanced case of double primary malignancy involving the breasts and uterine cervix: satisfactory response to non-surgical management. European Journal of Gynaecological Oncology. 2000. 21(1);102-104.
[1] Doh A. S., Choudong V. N. N.: "Double primary malignancies in patients with gy naecological cancers". Afr. J. Reprod. Health., 1998, 1, 2, 96.
[2] Vernon S. W., Tilley B. ·c., Naele J. A. V., Steinfeldt L.: "Ethnicity, survival and delay in seeking treatment for symptoms of breast cancer". Cancer, 1985, 55, 1563.
[3] Chardot C., Bey P.: "Protocoles d'investigations et de traitements pour les cancers". 1991. C.C.V. Publishers, France.
[4] Sananes C., Giaroli A., Soderini A., Guardado N., Snaidas L., Bermudez A. et al.: "Neoadjuvant chemotherapy followed by radical hysterectomy and postoperative adjuvant chemotherapy in the treatment of carcinoma of the uterine cervix: long term follow-up of a pilot study ". Eur. J. Gynaec. Oneal., 1998, XIX, 4, 368.
[5] Shinzaburo N., Keisuke M. et al.: "Induction of progesterone receptor with tamoxifen in human breast cancer with special reference to its behavior over time". Cancer, 1988, 61, 1345.
Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.
Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.
Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.
JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.
Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.
BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.
Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.
Top